Target Identification in Lupus (TIL) Grants
Funding Amount
Varies
Deadline
Rolling / Open
Grant Type
foundation
Overview
Target Identification in Lupus (TIL) Grants
Overview: The Target Identification in Lupus (TIL) program supports ingenious and determined scientific investigators in their quest to bring new understanding of lupus and ways to treat, prevent, and cure it. The program focuses on identifying novel molecular targets for lupus therapy.
Program Focus:
Geographic Scope: United States (institutions include Yale University, University of Washington, New York University School of Medicine, Brigham and Women's Hospital, University of Massachusetts Medical School, UT Southwestern Medical Center, The Feinstein Institute, and others)
Research Areas Funded:
Recent Awardees Examples:
Contact: Lupus Research Alliance, 52 Vanderbilt Ave, Suite 401, New York, NY 10017 | 646-884-6000
How to Apply
Application Process
Detailed application procedures and submission requirements are not provided in the available website content. Prospective applicants should visit the Lupus Research Alliance website or contact the organization directly.
Contact for More Information:
Focus Areas & Funding Uses
Fields of Work
Categories
Browse similar grants by category
Related Grants
Similar grants from this funder and related organizations
Nemaline Myopathy Research Grants (RFA)
Amount
Up to $100,000 per year for up to three years (up to five grants available)
Deadline
Rolling / Open
WAM Research Grant Program
Amount
Varies
Deadline
Rolling / Open
Paul E. Strandjord Young Investigator Grant
Amount
$7,500
Deadline
December 12, 2026
Jonas Environmental Health Education Project
Amount
$435,000
Deadline
Rolling / Open
Michelson Prizes: Next Generation Grants
Amount
$150,000
Deadline
Rolling / Open
BMS Small Grant
British Mycological Society
Amount
Up to £500
Deadline
Rolling / Open
Ready to apply for Target Identification in Lupus (TIL) Grants?
Grantable helps you assess fit, draft narratives, and track deadlines — so you can submit stronger applications, faster.